Showing results (1301-1310 of 4,516) with videos related to
Sort By:
Pageof 452
Future Oncology (London, England)|July 8, 2011
Afatinib (BIBW 2992) development in non-small-cell lung cancerVera HirshFuture Oncology (London, England)|July 8, 2011
Ridaforolimus: a promising drug in the treatment of soft-tissue sarcoma and other malignanciesJanet E Dancey, Jose MonzonFuture Oncology (London, England)|June 17, 2011
Examining the role of cyclin D1 in breast cancerMarco A Velasco-Velázquez, Zhiping Li, Mathew Casimiro, et al.Future Oncology (London, England)|May 17, 2011
Ubiquitin-specific proteases as cancer drug targetsWolfgang Sippl, Vincent Collura, Frédéric CollandFuture Oncology (London, England)|May 17, 2011
Improving oncology outcomes through targeted therapeutics will require electronic delivery systemsTibor van Rooij, Sharon MarshFuture Oncology (London, England)|January 10, 2015
Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activityCamillo Porta, Palma Giglione, Wanda Liguigli, et al.Future Oncology (London, England)|January 10, 2015
Risk of fatigue and hepatic and metabolic toxicities in patients with solid tumors treated with everolimus: a meta-analysisOmar Abdel-Rahman, Mona FouadFuture Oncology (London, England)|January 10, 2015
Pathology, therapy and prognosis of papillary renal carcinomaDiana Silva Fernandes, José Manuel LopesFuture Oncology (London, England)|January 10, 2015
Pembrolizumab joins the anti-PD-1 armamentarium in the treatment of melanomaPeter Hersey, Kavitha GowrishankarFuture Oncology (London, England)|January 17, 2015
Bevacizumab with chemotherapy in patients with KRAS wild-type metastatic colorectal cancer: Czech registry dataKateřina Kubáčková, Zbyněk Bortlíček, Tomáš Pikus, et al.Pageof 452